JP2000032946A - Functional food - Google Patents
Functional foodInfo
- Publication number
- JP2000032946A JP2000032946A JP10206135A JP20613598A JP2000032946A JP 2000032946 A JP2000032946 A JP 2000032946A JP 10206135 A JP10206135 A JP 10206135A JP 20613598 A JP20613598 A JP 20613598A JP 2000032946 A JP2000032946 A JP 2000032946A
- Authority
- JP
- Japan
- Prior art keywords
- water
- mycelium
- functional food
- himematsutake
- fruit body
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Preparation Of Fruits And Vegetables (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
Description
【0001】[0001]
【発明の属する技術分野】本発明は、姫マツタケの有効
成分を効果的に摂取することができる機能性食品に関す
る。BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a functional food capable of effectively ingesting the active ingredient of Himematsutake.
【0002】[0002]
【従来の技術】担子菌類には抗腫瘍性物質を含有するも
のが多く、特に、姫マツタケは、抗癌作用、癌予防効
果、肝機能改善効果、消化管運動亢進作用、抗アレルギ
ー作用、血糖降下作用、コレステロール低下作用、ビタ
ミンD2様作用、免疫促進効果などの多くの薬理効果を
もつことが知られている〔Food Style 21, 1997. 10,(v
ol. 1, No.5),第25〜30頁〕。2. Description of the Related Art Basidiomycetes often contain antitumor substances. In particular, Himematsutake has an anticancer effect, a cancer preventive effect, a liver function improving effect, a gastrointestinal motility enhancing effect, an antiallergic effect, and blood glucose. It is known to have many pharmacological effects such as a hypotensive effect, a cholesterol lowering effect, a vitamin D 2- like effect, and an immunostimulating effect [Food Style 21, 1997.
ol. 1, No. 5), pp. 25-30].
【0003】姫マツタケの上記薬理活性成分の本体は、
中性多糖(β−グルカン)、酸性ヘテロ多糖(ガラクト
グルカンのウロナイド)、蛋白多糖(ペプチドグルカ
ン)、核酸成分(リボヌクレオチド蛋白)など多様であ
り、その中でも(1→6)−β−D−グルカン−蛋白複
合体(FIII−2−b)が最も高い抗癌作用を有するこ
とが知られている。The main body of the above-mentioned pharmacologically active ingredient of Hime Matsutake is
Neutral polysaccharide (β-glucan), acidic heteropolysaccharide (uronide of galactoglucan), protein polysaccharide (peptide glucan), nucleic acid component (ribonucleotide protein), etc., among which are (1 → 6) -β-D- It is known that the glucan-protein complex (FIII-2-b) has the highest anticancer activity.
【0004】これらの活性成分のうち、(1→3)−β
−D−グルカン−蛋白複合体は水溶性であり、姫マツタ
ケの子実体又は菌糸体を熱水抽出すれば取得されるが、
(1→6)−β−D−グルカン−蛋白複合体(FIII−
2−b)は水に不溶性であり、水溶性多糖体を抽出し終
った残渣を、更に5%苛性ソーダ水溶液で抽出すること
によって初めて得られるものである。[0004] Among these active ingredients, (1 → 3) -β
The -D-glucan-protein complex is water-soluble, and is obtained by extracting the fruit body or mycelium of Himematsutake with hot water,
(1 → 6) -β-D-glucan-protein complex (FIII-
2-b) is insoluble in water and can be obtained only by extracting the residue obtained by extracting the water-soluble polysaccharide with a 5% aqueous sodium hydroxide solution.
【0005】[0005]
【発明が解決しようとする課題】従って、姫マツタケの
子実体又は菌糸体を食品として食した場合には、その活
性成分のうちの水溶性多糖体は摂取できるが、(1→
6)−β−D−グルカン−蛋白複合体のような水不溶性
グルカンは摂取できないという欠点があり、これまで、
姫マツタケのエキス服用は行われているが、子実体又は
菌糸体は機能性食品として食されていなかった。Therefore, when the fruit body or mycelium of Himematsutake is eaten as a food, the water-soluble polysaccharide of the active ingredient can be ingested, but (1 →
6) There is a drawback that water-insoluble glucans such as -β-D-glucan-protein complex cannot be ingested.
The princess matsutake extract was taken, but the fruit body or mycelium was not eaten as a functional food.
【0006】従って、本発明は、姫マツタケの子実体又
は菌糸体中の水溶性グルカン及び水不溶性グルカンを効
果的に摂取することのできる機能性食品を提供せんとす
るものである。Accordingly, an object of the present invention is to provide a functional food capable of effectively ingesting a water-soluble glucan and a water-insoluble glucan in the fruit body or mycelium of Himematsutake.
【0007】[0007]
【課題を解決するための手段】斯かる実情において、本
発明者は、上記課題を解決せんと鋭意研究を行った結
果、姫マツタケの子実体及び菌糸体を服用しても、少量
の蛋白質多糖複合体しか利用できないのは、子実体及び
菌糸体の細胞壁がキチン質及びヘミセルロースで構成さ
れており、極めて消化性が悪いことに原因すること、従
って、この強靱な細胞壁を破砕すれば、当該細胞壁中の
蛋白質多糖複合体を摂取できることを見出し、本発明を
完成した。Means for Solving the Problems Under such circumstances, the present inventors have conducted intensive studies to solve the above-mentioned problems. As a result, even if the fruit bodies and mycelia of Hime Matsutake were taken, a small amount of protein polysaccharide was obtained. Only the complex can be used because the cell wall of the fruiting body and mycelium is composed of chitin and hemicellulose, which is caused by extremely poor digestibility. Therefore, if this tough cell wall is crushed, The present inventors have found that the protein-polysaccharide conjugate can be ingested, and completed the present invention.
【0008】すなわち、本発明は、姫マツタケの子実体
又は菌糸体を20〜100メッシュに粉砕し、この粉砕
物に水を加えて20〜90重量%の懸濁液となし、この
懸濁液を直径0.5〜1.2mmの剛体メディアが80〜
85容量%満たされたシリンダーに送入し、50℃以下
の温度で回転混和し、得られたスラリーを乾燥して得ら
れる機能性食品を提供するものである。That is, the present invention relates to a method of pulverizing fruit bodies or mycelia of Himematsutake to a size of 20 to 100 mesh and adding water to the pulverized material to form a 20 to 90% by weight suspension. The rigid medium with a diameter of 0.5 to 1.2 mm is 80 to
This is to provide a functional food obtained by feeding the mixture into a cylinder filled with 85% by volume, rotating and mixing at a temperature of 50 ° C. or less, and drying the obtained slurry.
【0009】[0009]
【発明の実施の形態】本発明の機能性食品を製造するに
は、まず姫マツタケの子実体又は菌糸体を20〜100
メッシュに粉砕する。粉砕方法は特に限定されないが、
例えば子実体又は菌糸体を80℃程度で焙煎し、殺菌、
乾燥し、水分を5〜10%までとし、これをアルピネ、
ミル等を用いて粉砕する方法が挙げられる。また、10
0メッシュに近い細かい粉末を得るには、凍結粉砕が好
ましい。BEST MODE FOR CARRYING OUT THE INVENTION In order to produce the functional food of the present invention, first, the fruiting bodies or mycelia of Hime Matsutake are prepared in a proportion of 20 to 100.
Crush into mesh. The grinding method is not particularly limited,
For example, roasting fruit body or mycelium at about 80 ° C, sterilizing,
Dry to a water content of 5-10%,
A method of pulverizing using a mill or the like may be used. Also, 10
To obtain a fine powder close to 0 mesh, freeze pulverization is preferred.
【0010】得られた粉体は、水を加え、濃度20〜9
0重量%の水懸濁液とする。この濃度が20%未満であ
ると、次の工程の作業効率が悪くなり、生産性が低下
し、経済的に不利である。一方、90重量%を超える
と、次工程に用いる密閉シリンダーの中で、摩砕を行う
ための剛体メディアと子実体又は菌糸体の水懸濁液とが
一緒に回転してしまい、摩砕が不充分となるため好まし
くない。The obtained powder is added with water to a concentration of 20-9.
A 0% by weight aqueous suspension is obtained. If this concentration is less than 20%, the work efficiency of the next step is reduced, the productivity is reduced, and it is economically disadvantageous. On the other hand, if the content exceeds 90% by weight, the rigid medium for grinding and the aqueous suspension of the fruiting body or mycelium rotate together in the closed cylinder used in the next step, and the grinding is stopped. It is not preferable because it becomes insufficient.
【0011】子実体又は菌糸体の水懸濁液は、剛体メデ
ィアが80〜85%(容量)満たされているシリンダー
に送入される。この剛体メディアの直径は0.5〜1.
2mmであり、材質はジルコン又はジルコニアビーズが好
ましい。また剛体メディアはシリンダーの内容積の80
〜85重量%を満たす量を用いるが、この範囲を逸脱す
ると破砕効率及び生産性が悪くなり好ましくない。An aqueous suspension of fruiting bodies or mycelia is fed into a cylinder filled with rigid media of 80-85% (volume). The diameter of the rigid medium is 0.5-1.
2 mm, and the material is preferably zircon or zirconia beads. Rigid media has a cylinder inner volume of 80%.
An amount that satisfies 8585% by weight is used. However, if it is out of this range, the crushing efficiency and the productivity are unfavorably deteriorated.
【0012】子実体又は菌糸体の水懸濁液は剛体メディ
アと共に、回転羽根により回転・混和する。この回転・
混和によって、剛体メディアと回転羽根の摩砕作用によ
り細胞壁が破壊されるが、同時に熱が発生する。これを
放置すると、得られる子実体又は菌糸体の細胞破砕物の
品質が悪化するため、温度を50℃以下に保たなければ
ならない。温度を50℃以下に保つには、前記子実体又
は菌糸体の水懸濁液を前もって冷却しておくか、シリン
ダーの外部に冷却外套等の冷却装置を設ける等の処置が
行われる。なお、回転羽根の材質は焼入鋼、ステンレス
スチール、アルミナ、硬質ゴムが好ましく、形状は円盤
形で矢じり状の切込みが入っているものが好ましく、そ
の回転数は2,000〜3,500rpm とすることが好
ましい。The water suspension of the fruit body or mycelium is rotated and mixed with the rigid medium by the rotating blades. This rotation
The mixing destroys the cell wall due to the grinding action of the rigid medium and the rotating blades, but at the same time generates heat. If left undisturbed, the quality of the obtained cell debris of the fruiting bodies or mycelia deteriorates, so that the temperature must be kept at 50 ° C. or lower. In order to keep the temperature at 50 ° C. or lower, a treatment such as cooling the water suspension of the fruiting body or mycelium in advance or providing a cooling device such as a cooling jacket outside the cylinder is performed. The material of the rotating blades is preferably hardened steel, stainless steel, alumina, or hard rubber, and the shape is preferably a disc shape with a barbed notch, and the rotation speed is 2,000 to 3,500 rpm. Is preferred.
【0013】上記方法を実施するための装置としては、
冷却外套を備えた連続湿式微粉砕機が好ましく、市販の
ものとしてはダイノ−ミル(DYNO-MILL, Willy A. Bach
ofenAG Maschinenfabrik )が好適である。ダイノ−ミ
ルを用いる場合は、前記懸濁液の流量を5〜150l/
hrとすることが好ましい。An apparatus for performing the above method includes:
A continuous wet pulverizer equipped with a cooling jacket is preferred, and commercially available products are DYNO-MILL, Willy A. Bach
ofenAG Maschinenfabrik) are preferred. When using a dyno-mill, the flow rate of the suspension is 5 to 150 l /
hr is preferable.
【0014】以上の如くして、得られた子実体又は菌糸
体の細胞破砕物のスラリーは、次の乾燥工程を経て、製
品化される。乾燥は、当該細胞破砕物が変質しない方法
であれば特に限定されないが、工業的には減圧真空乾燥
による方法が好ましい。なお前記スラリーが粘着性を増
しているため、乾燥工程中に乾燥機本体に付着し、焦げ
てしまうおそれがあるため、付着防止剤、例えばカルボ
キシメチルセルロース(CMC)の微結晶粉体を10〜
15%添加するのが好ましい。また、減圧乾燥機を用い
て乾燥する際の温度は、40〜60℃とすることが好ま
しい。As described above, the obtained slurry of the cell crushed product of the fruiting body or mycelium is produced through the following drying step. Drying is not particularly limited as long as the method does not alter the cell crushed product, but industrially, vacuum drying is preferred. Since the slurry has increased tackiness, it may adhere to the main body of the dryer during the drying step and may be burned.
It is preferable to add 15%. Further, the temperature at the time of drying using a reduced-pressure drier is preferably set to 40 to 60 ° C.
【0015】かくして得られる子実体又は菌糸体の細胞
破砕物は、従来の方法では全く破壊されなかった細胞壁
が破壊されており、その粒径は約90%以上が350メ
ッシュ以下である。この破砕物はそのまた機能性食品と
して服用することができる。The cell crushed product of the fruiting body or the mycelium thus obtained has the cell wall which has not been destroyed at all by the conventional method, and its particle size is about 90% or more and 350 mesh or less. This crushed product can also be taken as a functional food.
【0016】本発明の機能性食品は、上記のようにして
得られる子実体又は菌糸体の破砕物を、そのままあるい
は他の賦形剤等と共に、粉末剤、顆粒剤、錠剤、カプセ
ル剤等とすることができる。本発明の機能性食品の服用
量は特に制限されないが、1日1〜4gが好ましい。The functional food of the present invention is obtained by mixing the crushed fruit body or mycelium obtained as described above with powders, granules, tablets, capsules, etc., as such or together with other excipients. can do. The dosage of the functional food of the present invention is not particularly limited, but is preferably 1 to 4 g per day.
【0017】[0017]
【実施例】次に、実施例を挙げて本発明を更に詳細に説
明するが、本発明はこれらに限定されるものではない。Next, the present invention will be described in more detail with reference to examples, but the present invention is not limited to these examples.
【0018】実施例1 採取した姫マツタケの子実体1kgを80℃、120分間
焙煎し、殺菌、乾燥し、水分を11〜12%とし、これ
をアルピスを用いて5分間粉砕を行い5メッシュとし
た。これを更にボールミル((株)山本鉄工所製,ミル
ト2号B型)を用い、5分間粉砕し、50メッシュの姫
マツタケ子実体粉末を450g得た。なお、クラッシャ
ー粉砕前の姫マツタケ子実体の水分を60%として計算
すると5%のロスであった。得られた姫マツタケ子実体
粉末を電子顕微鏡で観察すると、まだ姫マツタケ細胞は
破壊されていないことが判った。このようにして得られ
た姫マツタケ子実体粉末に水を加え、濃度10%の水懸
濁液を調製し、温度を10℃にした。次いで直径0.5
〜1.2mmのジルコンビーズを密封シリンダー容量の8
0%封入したダイノ−ミル中に、前記懸濁液を流量15
l/hrにて送入した。密閉シリンダー中では焼入鋼製の
羽根が3200rpmで回転しており、これにより、ジル
コンビーズ及び前記懸濁液を回転・混和せしめ、姫マツ
タケ子実体の細胞壁を摩砕した。この時、同時に冷却外
套をセットし、温度を調節した。この結果細胞壁が完全
に粉砕された50℃の姫マツタケ子実体の細胞破砕物の
スラリーが連続して得られた。次に冷却機より5℃に冷
却した後、タンクにて貯蔵し、姫マツタケ子実体の細胞
破砕物のスラリーに10%のCMCを付着防止剤として
添加した後、減圧低温乾燥機を使用して、姫マツタケ子
実体細胞破砕物を得た。得られた姫マツタケ子実体細胞
破砕物は、その90%以上が350メッシュ以下であっ
た。Example 1 1 kg of the collected fruit body of Himematsutake was roasted at 80 ° C. for 120 minutes, sterilized and dried to a water content of 11 to 12%, crushed with Alpis for 5 minutes, and crushed to 5 mesh. And This was further pulverized for 5 minutes using a ball mill (Milt No. 2 type B, manufactured by Yamamoto Tekkosho Co., Ltd.) to obtain 450 g of a 50-mesh Himematsutake fruit body powder. In addition, when the moisture of the fruit body of Himematsutake before crusher pulverization was calculated as 60%, the loss was 5%. Observation of the obtained princess matsutake fruit body powder with an electron microscope revealed that the princess matsutake cells had not been destroyed yet. Water was added to the thus obtained powder of the fruit body of Himematsutake, and a 10% aqueous suspension was prepared at a temperature of 10 ° C. Then 0.5 diameter
~ 1.2mm zircon beads with a sealed cylinder capacity of 8
The suspension was flowed at a flow rate of 15% into a
1 / hr. The hardened steel blades were rotating at 3200 rpm in the closed cylinder, whereby the zircon beads and the suspension were rotated and mixed to grind the cell wall of the princess matsutake fruit body. At this time, a cooling jacket was set at the same time to adjust the temperature. As a result, a slurry of cell crushed bodies of Himematsutake fruit bodies at 50 ° C., in which the cell walls were completely crushed, was continuously obtained. Next, after cooling to 5 ° C. from a cooler, the mixture was stored in a tank, and 10% of CMC was added as an anti-adhesion agent to the slurry of the crushed cell bodies of Himematsutake fruiting bodies. And crushed fruit cells of Hime Matsutake fruit body. 90% or more of the obtained crushed himematsutake fruit body cell cells had a size of 350 mesh or less.
【0019】実施例2 実施例1の姫マツタケ子実体粉末(比較品)及び実施例
1で細胞壁を摩砕した姫マツタケ子実体細胞破砕物(本
発明品)の熱水抽出液について、酸加水分解処理後、ブ
ドウ糖及びアミノ酸を定量した。その結果は表1のとお
りである。Example 2 The hot water extract of the powdered fruit body of Himematsutake fruit body of Example 1 (comparative product) and the disrupted cell material of Himematsutake fruit body obtained by grinding the cell wall in Example 1 (product of the present invention) were subjected to acid hydrolysis. After the decomposition treatment, glucose and amino acids were quantified. Table 1 shows the results.
【0020】[0020]
【表1】 [Table 1]
【0021】表1から明らかなように、本発明品は比較
品に比較してブドウ糖量及び蛋白量が著しく高い。この
ことは本発明の姫マツタケ子実体の細胞破砕物は機能性
食品としてその有効成分を有効に利用できることを意味
するものである。As is evident from Table 1, the product of the present invention has a significantly higher glucose and protein content than the comparative product. This means that the crushed cell body of the himematsutake fruit body of the present invention can effectively utilize its active ingredient as a functional food.
【0022】実施例3 実施例1の姫マツタケ子実体の代りに姫マツタケ菌糸体
を使用して同様に処理し、姫マツタケ菌糸体の細胞破砕
物を製造した。この破砕物の水浸出液について、酸加水
分解処理後、糖及びアミノ酸を定量した。その結果は表
2のとおりである。Example 3 In the same manner as in Example 1 except that the Himematsutake mycelium was used instead of the Himematsutake fruiting body, a cell crushed product of Himematsutake mycelium was produced. With respect to the water leaching solution of this crushed product, sugar and amino acids were quantified after acid hydrolysis treatment. Table 2 shows the results.
【0023】[0023]
【表2】 [Table 2]
【0024】[0024]
【発明の効果】本発明の機能性食品は有効成分が水に浸
出するように破砕されているので、有効成分を効果的に
摂取することができる。The functional food of the present invention is crushed so that the active ingredient is leached out into water, so that the active ingredient can be ingested effectively.
Claims (1)
100メッシュに粉砕し、この粉砕物に水を加えて20
〜90重量%の懸濁液となし、この懸濁液を直径0.5
〜1.2mmの剛体メディアが80〜85容量%満たされ
たシリンダーに送入し、50℃以下の温度で回転混和
し、得られたスラリーを乾燥して得られる機能性食品。1. The method according to claim 1, wherein the fruit body or mycelium of Hime Matsutake is
Crush to 100 mesh, add water to this crushed product and add 20
9090% by weight of the suspension and
A functional food obtained by feeding a cylinder filled with 80 to 85% by volume of a rigid medium of up to 1.2 mm, mixing by rotation at a temperature of 50 ° C. or less, and drying the obtained slurry.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP10206135A JP2000032946A (en) | 1998-07-22 | 1998-07-22 | Functional food |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP10206135A JP2000032946A (en) | 1998-07-22 | 1998-07-22 | Functional food |
Publications (1)
Publication Number | Publication Date |
---|---|
JP2000032946A true JP2000032946A (en) | 2000-02-02 |
Family
ID=16518370
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP10206135A Pending JP2000032946A (en) | 1998-07-22 | 1998-07-22 | Functional food |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP2000032946A (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005065063A3 (en) * | 2004-01-12 | 2005-11-17 | Geir Hetland | Use of the mushroom agaricus blazei murill for the production of medicaments suitable for treating infections and allergies |
WO2011140623A1 (en) * | 2010-05-11 | 2011-11-17 | Universidade Federal De Minas Gerais - Ufmg | Formulation against leishmaniasis and use thereof |
WO2024019023A1 (en) * | 2022-07-20 | 2024-01-25 | バイオサイエンステクノロジー株式会社 | Production method for hydrocolloid using mushroom as starting material, mushroom powder production method, hydrocolloid using mushroom as starting material, and mushroom powder |
JP7475575B2 (en) | 2022-07-20 | 2024-04-30 | バイオサイエンステクノロジー株式会社 | Method for producing hydrocolloid made from mushrooms, method for producing mushroom powder, hydrocolloid made from mushrooms, and mushroom powder |
-
1998
- 1998-07-22 JP JP10206135A patent/JP2000032946A/en active Pending
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005065063A3 (en) * | 2004-01-12 | 2005-11-17 | Geir Hetland | Use of the mushroom agaricus blazei murill for the production of medicaments suitable for treating infections and allergies |
WO2011140623A1 (en) * | 2010-05-11 | 2011-11-17 | Universidade Federal De Minas Gerais - Ufmg | Formulation against leishmaniasis and use thereof |
WO2024019023A1 (en) * | 2022-07-20 | 2024-01-25 | バイオサイエンステクノロジー株式会社 | Production method for hydrocolloid using mushroom as starting material, mushroom powder production method, hydrocolloid using mushroom as starting material, and mushroom powder |
JP7475575B2 (en) | 2022-07-20 | 2024-04-30 | バイオサイエンステクノロジー株式会社 | Method for producing hydrocolloid made from mushrooms, method for producing mushroom powder, hydrocolloid made from mushrooms, and mushroom powder |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2974719B2 (en) | Direct compression cholestyramine tablets and solventless coatings thereof | |
CA2809279C (en) | Natural biocomposite powder prepared from pichia pastoris biomass, method of preparation and its use as excipient | |
CN101313741B (en) | Method of preparing novel composite aromatic condiment | |
JPH074170B2 (en) | High protein content granules derived from beer lees | |
CN107334096A (en) | A kind of method and its extract that active component is extracted from sea cucumber | |
CN106937961B (en) | Water-soluble ganoderma lucidum powder and preparation method thereof | |
JP2000032946A (en) | Functional food | |
JP2002209552A (en) | Immunostimulating food | |
JP2934658B2 (en) | Chlorella extract powder manufacturing method | |
CN109394976B (en) | Preparation method of fresh dendrobium officinale freeze-drying wall-breaking ultrafine powder | |
JP3362984B2 (en) | Manufacturing method of non-boiled edible princess mushroom | |
JP2526185B2 (en) | Method for producing cell wall-destroying Reishi fine powder | |
JP4143312B2 (en) | Food composition and method for producing the same | |
JP4418781B2 (en) | Propolis powder manufacturing method | |
JP3432342B2 (en) | Seasoning manufacturing method | |
JP2001178406A (en) | Hyaluronic acid-containing food | |
JP2011046621A (en) | Method for producing mixed crushed product of calcium compound and cellulose | |
JP2000007706A (en) | Preparation of dry chitin powder or dry chitosan powder | |
JP3217697U (en) | Package of water extract powder | |
JP2005162708A (en) | Method for extracting agaricus blazei and antitumor agent and health food containing said extract as active component | |
JP3422973B2 (en) | Method for increasing gamma-aminobutyric acid content in shredded grasses | |
JPH02240026A (en) | Treatment of ganoderma lucidum | |
JP2002017294A (en) | METHOD FOR PRODUCING MUSHROOM POWDER HIGHLY CONTAINING Β-d-GLUCAN | |
JP3493585B2 (en) | Blood pressure lowering and serum triglyceride lowering agent | |
JPS6147495B2 (en) |